|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Operating income | |||||
| Other expense (income) | |||||
| Loss on sale of business | |||||
| Net interest expense | |||||
| Other expense (income) | |||||
| Income from continuing operations before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net income from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net income | |||||
| Comprehensive income, net of tax | |||||
| Net income | |||||
| Changes in cumulative translation adjustment | |||||
| Changes in market value of derivative financial instruments, net of tax | |||||
| Comprehensive income | |||||
| Earnings per ordinary share | |||||
| Continuing operations (USD per share) | |||||
| Discontinued operations (USD per share) | |||||
| Basic earnings per ordinary share (USD per share) | |||||
| Diluted earnings per ordinary share (USD per share) | |||||
| Weighted average ordinary shares outstanding | |||||
| Basic (shares) | |||||
| Diluted (shares) |
Loading...
